164 related articles for article (PubMed ID: 37787425)
21. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemistry for FOSB and FOS is a Useful Ancillary Tool in the Diagnosis of Epithelioid Hemangioma but There are Pitfalls in Interpretation Including Expression in Other Vascular Lesions.
Tsui KY; Maclean F; Moir D; Cheah A; Bonar F; Tabot J; Gill AJ; Vargas AC
Int J Surg Pathol; 2023 May; 31(3):280-288. PubMed ID: 35635207
[No Abstract] [Full Text] [Related]
23. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma.
Doyle LA; Mariño-Enriquez A; Fletcher CD; Hornick JL
Mod Pathol; 2015 Jul; 28(7):904-12. PubMed ID: 25857825
[TBL] [Abstract][Full Text] [Related]
24. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.
Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
[TBL] [Abstract][Full Text] [Related]
25. Spitzoid melanoma with histopathological features of ALK gene rearrangement exhibiting ALK copy number gain: a novel mechanism of ALK activation in spitzoid neoplasia.
Farah M; Nagarajan P; Curry JL; Tang Z; Kim TB; Aung PP; Torres-Cabala CA; Eterovic AK; Wargo JA; Prieto VG; Tetzlaff MT
Br J Dermatol; 2019 Feb; 180(2):404-408. PubMed ID: 29897634
[TBL] [Abstract][Full Text] [Related]
26. Epithelioid and Spindle Cell Hemangioma: Clinicopathologic Analysis of 18 Primary Bone and Soft Tissue Tumors Highlighting a Predilection for the Hands and Feet, Frequent Multicentricity, and Benign Behavior.
Papke DJ; Jagannathan J; Dong F; Dickson BC; Mertens F; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2023 Feb; 47(2):147-156. PubMed ID: 36206448
[TBL] [Abstract][Full Text] [Related]
27. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
28. Pediatric Mesothelioma With ALK Fusions: A Molecular and Pathologic Study of 5 Cases.
Argani P; Lian DWQ; Agaimy A; Metzler M; Wobker SE; Matoso A; Epstein JI; Sung YS; Zhang L; Antonescu CR
Am J Surg Pathol; 2021 May; 45(5):653-661. PubMed ID: 33399341
[TBL] [Abstract][Full Text] [Related]
29. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors.
Gestrich CK; Davis JL; Biederman L; John I; Alaggio R; Giovannoni I; Arnold MA; Shenoy A; Tchakarov A; Al-Ibraheemi A
Mod Pathol; 2023 Dec; 36(12):100334. PubMed ID: 37726067
[TBL] [Abstract][Full Text] [Related]
30. TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins.
Armstrong F; Lamant L; Hieblot C; Delsol G; Touriol C
Eur J Cancer; 2007 Mar; 43(4):640-6. PubMed ID: 17276053
[TBL] [Abstract][Full Text] [Related]
31. Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia.
Giuriato S; Foisseau M; Dejean E; Felsher DW; Al Saati T; Demur C; Ragab A; Kruczynski A; Schiff C; Delsol G; Meggetto F
Blood; 2010 May; 115(20):4061-70. PubMed ID: 20223922
[TBL] [Abstract][Full Text] [Related]
32. Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements.
Chang JC; Zhang L; Drilon AE; Chi P; Alaggio R; Borsu L; Benayed R; Travis WD; Ladanyi M; Antonescu CR
J Thorac Oncol; 2019 May; 14(5):825-834. PubMed ID: 30550870
[TBL] [Abstract][Full Text] [Related]
33. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
[TBL] [Abstract][Full Text] [Related]
34. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract][Full Text] [Related]
35. Corresponding anaplastic lymphoma kinase-tropomyosin 3 (
Melchers RC; Willemze R; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Vermeer MH; Quint KD
JAAD Case Rep; 2019 Nov; 5(11):970-972. PubMed ID: 31687467
[No Abstract] [Full Text] [Related]
36. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F
Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960
[TBL] [Abstract][Full Text] [Related]
37. Multiple Eruptive Epithelioid Hemangiomas: A Subset of Cutaneous Cellular Epithelioid Hemangioma With Expression of FOS-B.
Llamas-Velasco M; Kempf W; Cota C; Fernández-Figueras MT; Lee J; Ferrara G; Sander C; Shapiro PE; Requena L; Kutzner H
Am J Surg Pathol; 2019 Jan; 43(1):26-34. PubMed ID: 29266025
[TBL] [Abstract][Full Text] [Related]
38. A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation.
Zhao S; Liu W; Li S; Shi T; Chen Q; Li Q; Sun L; Ren D; Song Z; Huang C; Xu S
Cancer Res Treat; 2021 Apr; 53(2):601-606. PubMed ID: 33091968
[TBL] [Abstract][Full Text] [Related]
39. Epithelioid haemangioma of bone: A series of four cases with a revision of this contentious entity.
Bansal D; Pasricha S; Sharma A; Pruthi M; Tiwari A; Gupta G; Durga G; Kamboj M; Mahawar V; Jajodia A; Mehta A
Indian J Pathol Microbiol; 2022; 65(2):401-405. PubMed ID: 35435379
[TBL] [Abstract][Full Text] [Related]
40. A unique epithelioid vascular neoplasm of bone characterized by EWSR1/FUS-NFATC1/2 fusions.
Dashti NK; Dickson BC; Zhang L; Xie Z; Nielsen GP; Antonescu CR
Genes Chromosomes Cancer; 2021 Nov; 60(11):762-771. PubMed ID: 34310785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
